MELATONIN AND THE PATHOLOGY OF THE ELDERLY
- Authors: Kvetnoy I.1, Kvetnaya T.2, Bocharova K.3
-
Affiliations:
- D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences
- Saint Petersburg Institute of Bioregulation and Gerontology, North-Western Branch, Russian Academy of Medical Sciences
- Belgorod State National Research University
- Issue: Vol 25, No 6 (2014)
- Pages: 53-56
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116067
- ID: 116067
Cite item
Open Access
Access granted
Abstract
The paper considers a wide range of problems associated with the physiological effects of melatonin and the possibilities of its use in the diagnosis, treatment, and prevention of the pathology of the elderly.
Keywords
Full Text
About the authors
I. Kvetnoy
D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences
Email: igor.kvetnoy@yandex.ru
T. Kvetnaya
Saint Petersburg Institute of Bioregulation and Gerontology, North-Western Branch, Russian Academy of Medical Sciences
K. Bocharova
Belgorod State National Research UniversityCandidate of Medical Sciences
References
- Кветная Т.В., Князькин И.В. Мелатонин: роль и значение в возрастной патологии / СПб: ВмедА, 2004; 111 с.
- Кветной И.М., Левин И.М. Мелатонин и опухолевый рост // Экспер. онкол. - 1986; 4: 11-5.
- Castrillon P., Esquifino A., Varas A. Effect of melatonin theatment on 24th variations in responses to mitogens and lymphocyte subset populations in rat submaxillary lymph nodes // J. Neuroendocrinol. - 2000; 12 (8): 758-65.
- Cardinali D., Furio A., Reyes M. Clinical perspectives for the use of melatonin as a chronobiotic and cytoprotective agent // Ann. N. Y. Acad. Sci. - 2005; 1057: 327-36.
- Reiter R. Melatonin: clinical relevance // Best Pract. Res. Clin. Endocrinol. Metab. - 2003; 17 (2): 273-85.
- Анисимов В.Н., Арутюнян А.В., Хавинсон В.Х. Антиоксидантная роль эпиталамина и мелатонина. Геронтологические аспекты пептидной регуляции функций организма / СПб.: Наука, 1996; с. 15.
- Репетий Н.Г. К вопросу о значении мелатонина в этиопатогенезе артериальной гипертонии у лиц пожилого возраста // Успехи геронтол. - 2005; 16: 105-9.
- Aoki M., Yokota Y., Hayashi T. et al. Disorder of the saliva melatonin circadian rhythm in patients with Meniere’s disease // Acta Neurol. Scand. - 2006; 113 (4): 256-61.
- Анисимов В.Н., Кветной И.М., Комаров Ф.И. и др. Мелатонин в физиологии и патологии желудочно-кишечного тракта / М.: Советский спорт, 2000; 184 с.
- Малиновская Н.К., Комаров Ф.И., Рапопорт С.И. и др. Мелатонин в лечении язвенной болезни двенадцатиперстной кишки // Клин. мед. - 2006; 1: 5-11.
- Минушкин О.Н. Язвенная болезнь / М., 1995; 152 с.
- Arendt J. Melatonin: characteristics, concerns, and prospects // J. Biol. Rhythms. - 2005; 20 (4): 291-303.
- Maestroni G. The immunotherapeutic potential of melatonin // Exp. Opin. Investig.Drugs. - 2001; 10 (3): 467-76.
- Benitez-King G. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease // J. Pineal Res. - 2006; 40 (1): 1-9.
- Krause D., Dubocovich M. Melatonin receptors // Ann. Rev. Pharmacol. Toxicol. - 1991; 31: 549-68.
- Verdecchia P., Schillaci G., Gatteschi C. et al. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events // Circulation. - 1993; 88 (3): 986-92.
- Grossman E., Laudon M., Zisapel N. Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials // Vascular Health and Risk Management. - 2011; 7: 577-84.
- Wade A., Ford I., Crawford G. et al. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes // Cur. Med. Res. Opin. - 2007; 23 (10): 2597-605.
- Кветная Т.В., Князькин И.В., Кветной И.М. Мелатонин - нейроэндокринный маркер возрастной патологии / СПб: ДЕАН, 2005; 144 с.
Supplementary files
